Ho Lin

Shantou University — China

Medicine · Health Sciences

35h-index4.0kcitations293works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(31), Hormonal and reproductive studies(14), Prostate Cancer Treatment and Research(13), Cancer, Lipids, and Metabolism(11), Lung Cancer Treatments and Mutations(10)

Publications291 total

Sugar rationing during the first 1000 days of life and lifelong risk of heart failure
Nature Communications·2026Open Access
Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR-mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors
Anti-Cancer Drugs·2025
Preoperative albumin-to-fibrinogen ratio as a predictor of postoperative hospital stay in locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy
Scientific Reports·2025Open Access
Alisertib inhibits acute myeloid leukemia cell growth by inhibiting STAT3 activation
Toxicology and Applied Pharmacology·2025· 1 cited
Correction: The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
Cell Death and Disease·2025Open Access
CDK5 targets p21<sup>CIP1</sup> to regulate thyroid cancer cell proliferation and malignancy in patients
Molecular Medicine Reports·2025· 2 citedOpen Access
Dinaciclib Interrupts Cell Cycle and Induces Apoptosis in Oral Squamous Cell Carcinoma: Mechanistic Insights and Therapeutic Potential
International Journal of Molecular Sciences·2025· 7 citedOpen Access
Association of neighborhood-level sociodemographic factors with Direct-to-Consumer (DTC) distribution of COVID-19 rapid antigen tests in 5 US communities
UNC Libraries·2025Open Access
Life's Essential 8 and kidney stones in US adults: mediating roles of HDL and insulin resistance
Minerva Urology and Nephrology·2025· 4 cited
Impact of cholesterol on disease progression
Biomedicine·2024Open Access
Retinoic acid and cancer treatment
Biomedicine·2024· 1 citedOpen Access
PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024· 6 cited
Using a Polygenic Risk Score to Improve the Risk Prediction of Non–Small Cell Lung Cancer in Taiwan
JCO Precision Oncology·2024· 3 cited
SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade
Cell Death and Disease·2024· 14 citedOpen Access
Metformin inhibits nerve growth factor-induced sympathetic neuron differentiation through p35/CDK5 inhibition
American Journal of Physiology-Cell Physiology·2024· 7 cited
Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways
Chemosphere·2024· 9 cited
Metformin alters dendrite development and synaptic plasticity in rat cortical neurons
Biochemical and Biophysical Research Communications·2024· 14 cited
p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer
Anticancer Research·2024· 8 cited
Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways
Toxicology in Vitro·2023· 8 cited
762P Pamiparib combined with surufatinib as a neoadjuvant therapy for advanced ovarian cancer patients in the entire population: Preliminary results of a prospective, exploratory, single-arm phase II clinical study
Annals of Oncology·2023· 1 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Chih‐Ho Lai(16), Jer‐Tsong Hsieh(16), Mei-Chih Chen(11), Paulus S. Wang(11), U‐Ging Lo(8), Chun‐Jung Lin(6), Dalin He(5), Yuan Chen(5), Chia-Herng Yue(4), Eun-Jin Yun(4), Pao-Hsuan Huang(3), Chih‐Yang Huang(3), Hsin‐Yi Wang(3), Andrew Dang(3), John Santoyo(3), Jun Huang(3), Elizabeth Hernández(3), Chieh‐Lin Jerry Teng(3), Fu-Ning Hsu(3), Eugene Lin(3)